Focal adhesion kinase expression is not a prognostic predicator in colon adenocarcinoma patients

European Journal of Surgical Oncology

Volumn 29, Issue 7, 2003, Pages 571-574

  Theocharis, S E ^a   Kouraklis, Gregory P ^b   Kakisis, J D ^b   Kanelli, H G ^a   Apostolakou, F E ^a   Karatzas, G M ^b   Koutselinis, A S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Colon adenocarcinoma; Focal adhesion kinase; Immunohistochemistry

Indexed keywords

FOCAL ADHESION KINASE; KI 67 ANTIGEN; PROTEIN TYROSINE KINASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON MUCOSA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SAMPLE; SIGNAL TRANSDUCTION;

EID: 0141672910     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00120-3     Document Type: Article

References (27)

1. Richardson A, Parsons JT. Signal transduction through integrins: a central role for focal adhesion kinase? Bioessays 1995; 17: 229-36.
2. Hanks SK, Polte TR. Signaling through focal adhesion kinase. Bioessays 1997; 19: 137-45.
3. Juliano R. Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessays 1996; 18: 911-7.
4. Jockusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M, et al. The molecular architecture of focal adhesions. Annu Rev Cell Dev Biol 1995; 11: 379-416.
5. Macphee D, Lye S. Focal adhesion signaling in the rat myometrium is abruptly terminated with onset of labor. Endocrinology 2000; 141: 274-83.
6. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp 125 FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992; 89: 5192-6.
7. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-cleficient mice. Nature 1995; 377: 539-44.
8. Cary LA, Chang JF, Guan JL. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996; 109: 1787-94.
9. Guan JL, Trevithick JE, Hynes RO. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul 1991; 2: 951-64.
10. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: increased tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc Notl Acad Sci USA 1991; 88: 8392-6.
11. Xu LH, Owens LV, Sturge GC, Yang X, Liu ET, Craven RJ, et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 1996; 7: 413-8.
12. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Koengerg L, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995; 55: 2752-5.
13. Cobb BS, Schaller MD, Leu TH, Parsons JT. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol 1994; 14: 147-55.
14. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993; 342: 1024-5.
15. Withers BE, Hanks SK, Fry DW. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells. Cancer Biochem Biophys 1996; 15: 127-39.
16. Judson PL, He X, Cance WG, Van Le L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 1999; 86: 1551-6.
17. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol 1994; 1: 18-27.
18. McKay JA, Douglas JJ, Ross VG, Curran S, Loane JF, Ahmed FY, et al. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196: 386-93.
19. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996; 3: 100-5.
20. Han NM, Fleming RY, Curley SA, Gallick GE. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases:indepenence from c-src or c-yes activation. Ann Surg Oncol 1997; 4: 264-8.
21. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000; 6: 2417-23.
22. Levy P, Robin H, Kornprobst M, Capeau J, Cherqui G. Enterocytic differentiation of human Caco-2 cell line correlates with alterations in integrin signaling. J Cell Physiol 1989; 177: 618-27.
23. Iravani S, Mao W, Fu L, Karl R, Yeatman T, Jove R, et al. Elevated c-Src protein expression is an early event in colonic neoplasia. Lab Invest 1998; 78: 365-71.
24. Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 2001; 7: 3106-12.
25. Shibata K, Kikkawa F, Nawa A, Thant AA, Naruse K, Mizutani S, et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res 1998; 58: 900-3.
26. Abe Y, Tsutsui T, Mu J, Kosugi A, Yagita H, Sobue K, et al. A defect in cell-to-cell adhesion via integrin-fibronectin interactions in a highly metastatic tumor cell line. Jpn J Cancer Res 1997; 88: 64-71.
27. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 1999; 59: 1655-64.